Four faces of a parapneumonic effusion: Pathophysiology and varied radiographic presentations

Abstract

We report a patient methicillin-resistant Staphylococcus aureus pneumonia who developed fluid collections in three spaces in the thorax, the pleural space, the pericardial space, and a pre-existing bulla, in addition to mediastinal oedema. We discuss the universal pathogenesis for the development of these fluid collections and the explanation for the most common presentation being a parapneumonic effusion.

Listeria monocytogenes-associated respiratory infections: a study of 38 consecutive cases

“…Indeed, Lm is a foodborne pathogen, responsible for bacteraemia upon active crossing of the intestinal barrier [33]. Lung-tissue lesions and/or inflammation may facilitate Lm access from the blood to alveoli or from the parietal pleural capillary to the pleural space [34,35]. Haematogenous seeding is the most likely scenario for respiratory Lm infections, Lm being a foodborne pathogen that reaches the brain, placenta, and bones and joints via the haematogenous route [8,36,37].…”

The impact of dermatological toxicities of anti‐cancer therapy on the dermatological quality of life of cancer patients

“…Dermatological toxicities are common side effects of chemotherapy, radiotherapy and target therapy of cancer treatment; however, their prevalence and rate of severe occurrences differ considerably according to treatment modalities. 2,[8][9][10][11][12][13][14][15][16][17] Chemotherapy is an essential component in the multidisciplinary management of most cancers, and cutaneous reactions attributable to chemotherapy can result in patient morbidity and alteration of treatment plans.…”

The vanishing lung: an important cause of hyperlucency on chest radiograph

“…However similar to an uncomplicated parapneumonic effusion, most patients will respond to treatment with standard antibiotics. 10 Surgical resection of bullae is the treatment of choice in patients with giant bullous disease with normal adjoining lung parenchyma. It is potentially definitive treatment for a carefully selected group of patients with giant bullous disease as well as significant co-existent emphysema.…”